Mutational and structural analyses of the ribonucleotide reductase inhibitor Sml1 define its Rnr1 interaction domain whose inactivation allows suppression of mec1 and rad53 lethality.

Source:http://linkedlifedata.com/resource/pubmed/id/11074005

Download in:

View as

General Info

PMID
11074005